Deep tumor immunophenotyping in this study demonstrated the importance of expression profiling in NPC, especially given the paucity of existing biomarkers for checkpoint inhibitor response; TMB and PD-L1 expression show little or no association with response in NPC. The gene discussed is CD274; the disease is nasopharyngeal carcinoma.